I have another question which I asked a different panel. Because health care is administered by the provinces, there are restrictions on areas in which the federal government can have an influence on health care. But one area we do influence when it comes to innovation in health care is the area of medical devices and the regulation of products and the product approval process. Obviously, that's an important part of the process for health care innovation.
What is your opinion on what the federal government could do to make that process more efficient or effective in supporting innovation?